Research | Alzheimer's Prevention Registry

You are here


Alzheimer's: Rethinking the 'One-Size-Fits-All' Approach

Precision medicine in Alzheimer's disease -- tailoring prevention and treatment to a patient's unique risk profile -- surfaced as a key theme at the NIH National Institute on Aging (NIA) 2018 Alzheimer's Disease Research Summit.

NIH summit delivers recommendations to accelerate therapy development for Alzheimer’s disease

Experts from government, academia, industry, and non-profit organizations put forward recommendations that provide a roadmap for an integrated, multidisciplinary research agenda necessary to inform priorities for Alzheimer’s disease and related dementias. 

Ask the Expert: What is the difference between genetic markers and biomarker results?

Dear Dr. Stites: 
I’m trying to keep up on Alzheimer’s research. Repeatedly, I’m hearing the terms genetic markers and biomarker results. I’m a little embarrassed to admit this, but I’m not sure I know the difference. Can you enlighten me?

The Stigma of Alzheimer’s – When Understanding Leads to Hope

A recent study published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, confirmed what many may have assumed – when it comes to Alzheimer’s disease, there is a stigma. Often, this stigma serves as a barrier to research study participation because people are nervous about being discriminated against. By understanding the biggest concerns, it’s hoped that programs and policies can be developed to reduce the stigmas and offer more protections.

Eating a Mediterranean Diet Could Delay Alzheimer’s Disease By Years

A study published last month suggests that a Mediterranean diet isn’t just good for your heart and waistline but can also stave off the onset of Alzheimer’s disease by as much as three-and-a-half years.

POINTing the Way to Alzheimer’s Prevention

A massive $20 million research trial is kicking off to determine whether early intervention can support brain health and prevent decline in memory and thinking ability. Can lifestyle intervention – exercise, diet, social interaction and “brain exercise” really prevent Alzheimer’s?

Alzheimer's Stigma Hinders Research

Currently, several trials are trying to develop therapies for AD by 2025. These trials’ success, however, depends upon participants who are willing to undergo genetic and biomarker testing to learn if they are at risk of AD dementia. 

The Effects of Carbs on the Brain

Is Cutting Carbs Bad For Your Brain? A Neuroscientist Explains

Seeking your ideas for ways to enhance recruitment and retention of Alzheimer’s disease study participants

To address increasing concerns about difficulties in reaching study recruitment goals, the NIA, with co-facilitation from the Alzheimer’s Association and other organizations, is asking a wide range of stakeholders, particularly those underrepresented in research, to help develop a comprehensive National Strategy for Alzheimer’s Disease Clinical Research Recruitment and Participation.